AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Impact of a Paramedical Training Program for Nurses and Nursing Assistants on the Length of Stay and Prevention of Hospital Iatrogenic Complications in Elderly Patients

Recruitingn/aAges 75 Years - anyAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

In France, hospitalised elderly patients (EP) aged \>75 years are expected to represent 1/3 of patients by 2030 (22% in 2015). In acute care wards outside geriatrics, the average length of stay increases with age, i.e. 8.5 days after the age of 90 compared with 5.5 days for younger patients. Dependence related to hospitalisation, partly avoidable, occurs in 30 to 60% of patients aged over 70. Faced with this situation Geriatric Mobile Teams (GMT) were created in 2002 to meet the need for geriatric expertise in hospitals and in the community by making punctual evaluations. Expert and multidisciplinary, the GMTs are a referring team for "advice, information and training for health care teams" for the care of vulnerable EPs. The GMTs are dependent on an exclusively medical demand system. The lack of knowledge of a specific care for EPs by nurses and nursing assistants and the occasional con

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 75 years and over hospitalised in a participating specialtist wards * not objecting to the study, * including those under guardianship or curatorship. Exclusion Criteria: * Patient not affiliated to a social security scheme * Patient at the end of life
💊

What it tests

  • Training of nurses and nursing assistants
📍

Where

5 sites
Centre Hospitalier de Bourg en Bresse
Bourg-en-Bresse, France
Croix Rousse Hospital
Lyon, France
CH Annecy Genevois
Metz-Tessy, France
service de court séjour gériatrique, Hôpital Lyon Sud
Pierre-Bénite, France
Hôpital Nord-Ouest
Villefranche-sur-Saône, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy